BRPI0413820A - derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio - Google Patents

derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio

Info

Publication number
BRPI0413820A
BRPI0413820A BRPI0413820-1A BRPI0413820A BRPI0413820A BR PI0413820 A BRPI0413820 A BR PI0413820A BR PI0413820 A BRPI0413820 A BR PI0413820A BR PI0413820 A BRPI0413820 A BR PI0413820A
Authority
BR
Brazil
Prior art keywords
androgen receptor
cycloamino
modulating compounds
receptor modulating
quinolinone derivatives
Prior art date
Application number
BRPI0413820-1A
Other languages
English (en)
Inventor
Lin Zhi
Esther Martinborough
Yixing Shen
Thomas Lot Sevens Lau
Min Wu
Yun Oliver Long
Original Assignee
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34216080&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0413820(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ligand Pharm Inc filed Critical Ligand Pharm Inc
Publication of BRPI0413820A publication Critical patent/BRPI0413820A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Abstract

"DERIVADOS DE 6-CICLOAMINO-2-QUINOLINONA COMO COMPOSTOS MODULADORES DE RECEPTOR DE ANDROGêNIO". A presente invenção é dirigida a compostos, composições farmacêuticas e a métodos para modular processos mediados por AR. São também fornecidos métodos de preparar esses compostos e composições farmacêuticas.
BRPI0413820-1A 2003-08-22 2004-08-23 derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio BRPI0413820A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49712503P 2003-08-22 2003-08-22
PCT/US2004/027483 WO2005018573A2 (en) 2003-08-22 2004-08-23 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds

Publications (1)

Publication Number Publication Date
BRPI0413820A true BRPI0413820A (pt) 2006-10-24

Family

ID=34216080

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413820-1A BRPI0413820A (pt) 2003-08-22 2004-08-23 derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio

Country Status (9)

Country Link
US (1) US7816372B2 (pt)
EP (1) EP1656142A4 (pt)
JP (2) JP4709759B2 (pt)
CN (1) CN1838956A (pt)
AU (1) AU2004266160A1 (pt)
BR (1) BRPI0413820A (pt)
CA (1) CA2536349A1 (pt)
MX (1) MXPA06001751A (pt)
WO (1) WO2005018573A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026484B2 (en) 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods
US7214690B2 (en) 2001-02-23 2007-05-08 Ligand Pharmaceuticals Incorporated Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
BRPI0413820A (pt) * 2003-08-22 2006-10-24 Ligand Pharm Inc derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio
WO2005090282A1 (en) 2004-03-12 2005-09-29 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
EP1891067B1 (en) * 2005-06-17 2016-01-13 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
AU2006282767A1 (en) 2005-08-26 2007-03-01 The Regents Of The University Of California Non-steroidal antiandrogens
WO2007123682A2 (en) * 2006-04-03 2007-11-01 Medexis S.A. Detection of membrane androgen receptor (mar) agents
JP2009079037A (ja) * 2007-09-06 2009-04-16 Sumitomo Chemical Co Ltd アミロイドβタンパク質の蓄積を抑制するための医薬組成物
CA2709677C (en) * 2007-12-21 2017-03-14 Lin Zhi Selective androgen receptor modulators (sarms) and uses thereof
WO2012047617A1 (en) * 2010-09-28 2012-04-12 Radius Health, Inc. Selective androgen receptor modulators
AU2013353723B2 (en) 2012-12-03 2018-02-22 Pfizer Inc. Novel selective androgen receptor modulators
US10441567B2 (en) * 2014-01-17 2019-10-15 Ligand Pharmaceuticals Incorporated Methods and compositions for modulating hormone levels
EP3143019B1 (en) * 2014-05-15 2020-12-16 Pfizer Inc Crystalline form of 6-[(4r)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl]isoquinoline-1-carbonitrile
KR20160147007A (ko) * 2014-05-30 2016-12-21 화이자 인코포레이티드 선택적인 안드로겐 수용체 조절제로서의 카보니트릴 유도체
CA2992698A1 (en) 2015-07-17 2017-01-26 Toyama Chemical Co., Ltd. Nitrogen-containing heterocyclic compound
AU2017385292B2 (en) * 2016-12-27 2020-05-14 Fujifilm Corporation Antitumor agent and bromodomain inhibitor

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979394A (en) * 1970-12-11 1976-09-07 Agfa-Gevaert N.V. Duplo quinoline compounds
US4202895A (en) * 1971-06-04 1980-05-13 Sumitomo Chemical Company, Limited 1-Polyhaloalkyl-2(1H)-quinazolinone derivatives
US3847988A (en) 1971-12-23 1974-11-12 Schering Corp Substituted imidates
BE795696A (nl) * 1972-02-28 1973-08-21 Agfa Gevaert Nv Voor warmte gevoelige materialen
DE2334738A1 (de) 1973-07-09 1975-01-30 Henkel & Cie Gmbh Haarfaerbemittel
FR2329276A1 (fr) 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
US4138490A (en) * 1975-03-20 1979-02-06 Imperial Chemical Industries Limited Analgesic compositions containing 1,2-dihydro-2-oxoquinol-4-ylpropionic acid derivatives
IE43079B1 (en) * 1975-03-20 1980-12-17 Ici Ltd Quinolone derivatives
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
ATE28864T1 (de) 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
US4505852A (en) * 1982-11-29 1985-03-19 Enzyme Systems Products 7-Amino-4-trifluoromethylquinolone derived substrates and method for determining enzymes and inhibitors
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
NZ212209A (en) * 1984-05-29 1988-08-30 Pfizer Quinolone derivatives and pharmaceutical compositions
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5081242A (en) * 1986-12-22 1992-01-14 Ortho Pharmaceutical Corporation 6-benzoxazinyl- and 6-benzothiazinyl 2,3,4,5-tetrahydropyridazin-3-ones
GB8630702D0 (en) 1986-12-23 1987-02-04 Wellcome Found Quinoline compound
EP0303418A3 (en) * 1987-08-11 1990-11-07 Smithkline Beecham Laboratoires Pharmaceutiques Substituted indolones, useful in the treatment of heart or asthmatic diseases
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
WO1989007441A1 (en) 1988-02-10 1989-08-24 The Regents Of The University Of California 6-amino-1,2-benzopyrone antitumorigenic agents and method
DE3810706A1 (de) 1988-03-25 1989-10-05 Schering Ag Substituierte cumarinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider wirkung
GB8820174D0 (en) 1988-08-25 1988-09-28 Wellcome Found Quinoline compound
FR2683818B1 (fr) 1991-11-14 1993-12-31 Adir Cie Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO1993022317A1 (en) * 1992-05-01 1993-11-11 Kowa Co., Ltd. Quinoline derivative or salt thereof and remedy for cardiac diseases containing the same
WO1994023068A1 (en) 1993-04-07 1994-10-13 Ligand Pharmaceuticals, Incorporated Method for screening for receptor agonists
US5677336A (en) * 1993-10-21 1997-10-14 Ligand Pharmaceuticals Incorporated Non-steroid androgen receptor antagonist compounds and methods
US6696459B1 (en) * 1994-12-22 2004-02-24 Ligand Pharmaceuticals Inc. Steroid receptor modulator compounds and methods
US5693646A (en) * 1994-12-22 1997-12-02 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
NZ300739A (en) 1994-12-22 2000-05-26 Ligand Pharm Inc Steroid receptor modulator compounds
EP0832295A1 (en) 1995-06-07 1998-04-01 Ligand Pharmaceuticals Incorporated Method for screening for receptor agonists and antagonists
JP3964478B2 (ja) * 1995-06-30 2007-08-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
EP0918774B9 (en) 1996-06-27 2002-04-10 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
US6017924A (en) * 1996-06-27 2000-01-25 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
WO1998049155A1 (en) * 1997-04-25 1998-11-05 Takeda Chemical Industries, Ltd. Cell differentiation inducing amide derivatives, their production and use
US6506766B1 (en) 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
US6380207B2 (en) 1998-02-13 2002-04-30 Abbott Laboratories Glucocortiocoid-selective antiinflammatory agents
US6001846A (en) * 1998-02-17 1999-12-14 Ligand Pharmaceuticals Incorporated Process for the preparation of 1,2-dihydroquinolines
EP1077919A1 (en) 1998-05-11 2001-02-28 Novo Nordisk A/S New compounds, their preparation and use
AU754529B2 (en) 1998-09-22 2002-11-21 Yamanouchi Pharmaceutical Co., Ltd. Cyanophenyl derivatives
AT407876B (de) * 1999-04-30 2001-07-25 Georg Dr Uray Lumineszierende 4-trifluormethyl-2-chinolinone mit langwelliger uv-absorption und ihre verwendung
US6358948B1 (en) * 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6444668B1 (en) * 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6498154B1 (en) * 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6216462B1 (en) * 1999-07-19 2001-04-17 The United States Of America As Represented By The Administrator Of The Environmental Protection Agency High efficiency, air bottoming engine
CZ2002711A3 (cs) 1999-08-27 2003-11-12 Ligand Pharmaceuticals Incorporated Modulátory androgenních receptorů, způsoby jejich výroby a způsoby jejich použití
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
JP2003508397A (ja) * 1999-08-27 2003-03-04 リガンド・ファーマシューティカルズ・インコーポレイテッド アンドロゲンレセプターモジュレーターとしての８−置換−６−トリフルオロメチル−９−ピリド［３，２−ｇ］キノリン化合物
KR100731566B1 (ko) 1999-10-14 2007-06-22 가켄 세야쿠 가부시키가이샤 테트라히드로퀴놀린 유도체
EP1401801B1 (en) * 2000-08-24 2006-11-02 The University Of Tennessee Research Corporation Selective androgen receptor modulators and methods of use thereof
WO2002022585A1 (fr) 2000-09-14 2002-03-21 Kaken Pharmaceutical Co., Ltd. Composes de tetrahydroquinoline
US7026484B2 (en) * 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods
US7214690B2 (en) 2001-02-23 2007-05-08 Ligand Pharmaceuticals Incorporated Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
WO2003011824A1 (en) * 2001-07-31 2003-02-13 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
GB0126036D0 (en) 2001-10-30 2001-12-19 Amedis Pharm Ltd Silicon compounds
AU2003230869B2 (en) 2002-04-26 2010-02-25 Ortho-Mcneil Pharmaceutical, Inc. 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
HK1055058A2 (en) * 2002-10-11 2003-12-05 Ligand Pharm Inc 5-CYCLOALKENYL 5H-CHROMENO[3,4-f]QUINOLINE DERIVATIVES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
CA2501833A1 (en) * 2002-10-11 2004-04-22 Ligand Pharmaceuticals Incorporated 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5h-chromeno[3,4-f]quinolines as selective progesterone receptor modulator compounds
EP1567487A4 (en) 2002-11-15 2005-11-16 Bristol Myers Squibb Co OPEN-CHAINED, PROLYL-FROSTED MODULATORS OF ANDROGEN RECEPTOR FUNCTION
BRPI0413820A (pt) * 2003-08-22 2006-10-24 Ligand Pharm Inc derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio
WO2005090282A1 (en) 2004-03-12 2005-09-29 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
CA2709677C (en) 2007-12-21 2017-03-14 Lin Zhi Selective androgen receptor modulators (sarms) and uses thereof

Also Published As

Publication number Publication date
EP1656142A4 (en) 2011-06-22
US7816372B2 (en) 2010-10-19
JP4709759B2 (ja) 2011-06-22
CA2536349A1 (en) 2005-03-03
US20080227810A9 (en) 2008-09-18
WO2005018573A3 (en) 2005-05-06
JP2007503398A (ja) 2007-02-22
AU2004266160A1 (en) 2005-03-03
EP1656142A2 (en) 2006-05-17
WO2005018573A2 (en) 2005-03-03
JP2010195799A (ja) 2010-09-09
US20070066650A1 (en) 2007-03-22
CN1838956A (zh) 2006-09-27
MXPA06001751A (es) 2006-05-12

Similar Documents

Publication Publication Date Title
BRPI0413820A (pt) derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio
BRPI0410711A (pt) novos compostos
DE602004021472D1 (en) Pyrimiidinverbindungen
TW200612936A (en) Indole derivatives
MX2010003155A (es) Derivados de ciclopropil aril amida y uso de los mismos.
SG162804A1 (en) Pyrazole based lxr modulators
TW200505902A (en) Cannabinoid receptor ligands
MX2007005694A (es) Nuevos derivados de betulina, preparacion y uso de los mismos.
TW200626158A (en) Naphthaline derivatives
TW200613243A (en) Novel compounds
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
NZ596579A (en) Bace inhibitors
CY1111977T1 (el) Παραγωγα πιπεριδιν-4-υλ-πυριδαζιν-3-υλαμινης ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
MX2007011695A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
BR0213464A (pt) Derivados de 3-azabiciclo[3.1.0]hexano como antagonistas receptores de opióide
MX2008002805A (es) Derivados de carboxamida como antagonistas del receptor muscarinico.
ES2243579T3 (es) Derivados de pirazolopirideno.
CY1113759T1 (el) Ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2
ZA200604410B (en) Imidazole derivatives, processes for preparing them and their uses
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
MX2009006010A (es) Derivados de amina y su uso en enfermedades mediadas por el adrenoreceptor beta 2.
BRPI0606639A2 (pt) novo processo para a preparação de indóis substituìdos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]